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Ropivacaine (ROPI), which is less toxic and produces less
motorblock thanbupivacaine (BUPI), seemsattractive for
epidural analgesia. Few data are available concerning
doserequirementsofepiduralROPIwhencombinedwith
morphine. In this study, we compared the dose require-
ments and side effects of ROPI and BUPI combined with
small-dose morphine after major abdominal surgery.
Postoperatively, 60 patients were randomly allocated
(double-blinded manner) to four groups: patient-
controlledepiduralanalgesiawith thesamesettingsusing
0.1% or 0.2% solution of ROPI or BUPI combinedwith an
epidural infusion of 0.1 mg/h of morphine. Pain scores,
side effects, motor block, and local anesthetic consump-
tionweremeasured for60h.Painscoresand the incidence
of side effectsdidnotdiffer among thegroups.Consump-
tion of ROPI and BUPI were similar in both 0.1% groups.
Doubling the concentration significantly reduced the con-
sumption (milliliters) of BUPI (P! 0.05) but not of ROPI.
Consequently, using ROPI 0.2% significantly increased
the dose administered as compared with ROPI 0.1%
(ROPI 0.1% " 314 # 151 mg and ROPI 0.2% " 573 #
304mg at Hour 48; P! 0.05). Patient-controlled epidural
analgesiawith the 0.1% or 0.2% solution of ROPI or BUPI
combined with epidural morphine resulted in compara-
ble analgesia. As compared with ROPI 0.1%, the use of
ROPI 0.2% increased consumption of local anesthetic
without improving analgesia.
(AnesthAnalg 2002;95:444–9)
P ostoperative epidural analgesia using local anes-thetic may improve patient outcome after majorabdominal surgery (1,2). The more favorable
toxicity profile of ropivacaine (ROPI) as compared
with bupivacaine (BUPI) makes ROPI appealing for
postoperative epidural analgesia (3). Although epi-
dural ROPI produces less motor block than equal
doses of BUPI (4), the doses of ROPI required when
used alone to provide adequate analgesia after ab-
dominal surgery can result in significant motor block
(5). Combination with a lipophilic opioid allows re-
duction of the dose of ROPI, improves postoperative
analgesia (6,7), and reduces the incidence of motor
block (8), but is associated with undesirable opioid-
induced side effects (9). Small-dose epidural morphine
(0.2 mg/h) combined with BUPI provides effective
epidural analgesia after abdominal surgery (10,11).
However, little is known about the dose requirements
of ROPI when combined with small doses of epidural
morphine. Therefore, we conducted a randomized,
double-blinded study to determine the doses of two
different concentrations of ROPI (0.1% and 0.2%) re-
quired to produce adequate postoperative epidural
analgesia after major abdominal surgery when com-
bined with 0.1 mg/h of epidural morphine and to
compare their efficacy and side effects with those of
the same concentrations of BUPI.
Methods
After approval of our Institution Ethics Committee
and patient informed consent, 60 ASA physical status
I to III patients, scheduled for elective major abdomi-
nal surgery, were included in the study. After 6 h
NPO, all patients were orally premedicated with
50 mg of hydroxyzine and 0.5 mg of alprazolam 2 h
before surgery. In the operating room, an IV infusion
of 10 mL · kg$1 · h$1 of Ringer’s lactate solution was
started, and an epidural catheter was inserted at the
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T8-9 or T9-10 interspace. After an epidural test dose
(4 mL of lidocaine 1% with 1/200,000 of epinephrine),
0.1 mL/kg of BUPI 0.5% was injected, and a continu-
ous epidural infusion of 0.1 mL · kg$1 · h$1 of BUPI
0.25% was started in all patients. We used BUPI in all
patients to obtain the same recovery when epidural
anesthesia was stopped after surgery. General anes-
thesia was induced with propofol (2 mg/kg), sufen-
tanil (0.25 !g/kg), and cisatracurium (0.2 mg/kg) and
maintained with sevoflurane in 50% oxygen/air mix-
ture. Propacetamol 2 g (a precursor of paracetamol;
Pro-Dafalgan®, UPSA Medica, Belgium; 2 g of propa-
cetamol " 1 g of paracetamol or acetaminophen in the
United States) was given IV 30 min before the end of
surgery and then systematically every 6 h. At the end
of surgery, patients were awakened, and the epidural
infusion of 0.25% BUPI was stopped. Patients were
then randomly allocated in a double-blinded manner
to four epidural groups (n " 15 each): ROPI 0.1%,
ROPI 0.2%, BUPI 0.1%, or BUPI 0.2%. The local anes-
thetic solution was administered using a patient-
controlled epidural analgesia (PCEA) pump (Pain
Management Provider; Abbott, Abbott Park, IL).
PCEA settings were the same in the four groups and
were a 5-mL bolus dose, lockout interval of 10 min,
and no basal infusion. PCEA was combined with a
continuous epidural infusion of 0.1 mg/h of mor-
phine. Morphine was not mixed with the local anes-
thetic solution to keep the dose of morphine indepen-
dent of the volume of local anesthetic administered.
We selected a very small dose of morphine without an
initial dose. Indeed, in a pilot study, the administra-
tion of a 2-mg bolus of morphine followed by a con-
tinuous infusion of 0.2 mg/h, as used by Kehlet and
Mogensen (11), resulted in almost no administration
of local anesthetic by the patients. Rescue analgesia
was provided with IV infusion of 100 mg of tramadol
every 6 h if required. The following variables were
assessed 4 h after the end of surgery, and at 8:00 am,
1:00 pm, and 6:00 pm during postoperative Days 1 and
2: (a) pain score on a 100-mm visual analog scale at
rest, during coughing, and at mobilization from the
supine to the sitting position, (b) motor block using
the Bromage scale (1 " no motor block, 2 " knee
blocked and mobility of ankle preserved, 3 "mobility
of ankle difficult, and 4 " knee and ankle blocked),
and (c) the level of sensory block using the cold test.
Sedation score (0 " awake, 1 " drowsy, 2 " asleep,
and 3 " unconscious) and respiratory rate were mon-
itored by the nurses every 4 h. The volume of local
anesthetic solution administered by the patient was
recorded every 4 h. The need for rescue analgesic,
nausea, vomiting, pruritus, and orthostatic hypoten-
sion (systolic blood pressure !90 mm Hg) when the
patient was sitting in an armchair were also noted.
Because of the systematic use of a bladder catheter,
urinary retention was not reported.
Continuous variables are presented as mean # sd,
and categorical variables are represented as a number.
Analysis of variance for repeated measures for two
criteria (time and treatment) or the Student’s t-test
were used to compare continuous variables when ap-
propriate. Categorical data were analyzed using Fish-
er’s exact test. A value of P ! 0.05 was considered
significant.
Results
There were no significant differences among the four
groups with regard to demographic and intraoperative
data or type of surgery (Table 1). Pain scores at rest,
during coughing, and at mobilization were comparable
in the four groups (Fig. 1). Dermatomal extension of
sensory block did not differ among the four groups (Fig.
2). Local anesthetic consumption in milliliters every 4 h
is shown in Figure 3. There was a significant reduction of
local anesthetic consumption over time in each group (P
! 0.0001). The volumes of both 0.1% solutions adminis-
tered by the patients were quite similar. With BUPI,
increasing the concentration to 0.2% resulted in a signif-
icant reduction in the volume administered as compared
with the 0.1% solution (P! 0.05). However, the volumes
administered in both ROPI groups were not significantly
different. Consequently, the total dose (in milligrams) of
ROPI administered in the 0.2% group was significantly
larger than in the 0.1% group (P! 0.05) (Table 2). At the
postoperative Hour 48, the potency of ROPI as com-
pared with BUPI (ratio of required dose for equivalent
effect) was %1 (314:310) when using 0.1% solutions and
%1.3 (573:438) when using 0.2% solutions. Those ratios
remained constant between Hours 36 and 60. The need
for rescue analgesics was not significantly different in
the four groups (Table 3). The incidence of motor block
of the legs was infrequent and not different among the
groups (Table 3). Only one patient presented a high-
grade (Bromage scale &2) motor block in the BUPI 0.2%
group; however, no patient reported any motor block in
the ROPI 0.1% group. The incidence of nausea and pru-
ritus (Table 3) were small and not different among the
groups. Four to six patients in each group presented
transient orthostatic hypotension on Day 1 when they
were sitting in the armchair. These hypotensive episodes
all resolved after an accelerated infusion of 500 mL of
Ringer’s lactate solution. No decrease of the respiratory
rate below 10 breaths/min was observed. Sedation
scores were similar in the four groups and remained
below 3 for all patients.
Discussion
This study suggests that the average dose of ROPI re-
quired to provide adequate analgesia after major ab-
dominal surgery when given in combination with a con-
tinuous epidural infusion of morphine 0.1 mg/h is
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7–8mL/h during the first postoperative 24-h period and
5–6 mL/h the next 24 h whatever the concentration of
ROPI used (0.1% or 0.2%). Using PCEA combined with
small-dose morphine, the efficacy and profile of side
effects for 0.1% and 0.2% solutions of ROPI and BUPI
were similar.
Whereas doses of epidural ROPI approximately 20–
30 mg/h are required to provide good pain relief
Figure 1. Pain scores at rest, during mobilization, and on coughing
on a 100-mm visual analog scale. Data are mean. sem was omitted
for clarity. sem ranged between 2 and 6 mm at rest, between 3 and
8 mm during mobilization, and between 5 and 9 mm during cough-
ing. BUPI " bupivacaine and ROPI " ropivacaine.
Figure 2. Dermatomal extension of anesthesia to cold. Data are
mean # sem. BUPI " bupivacaine and ROPI " ropivacaine.
Figure 3. Local anesthetic consumption in milliliters after surgery.
Data are mean # sem. *P ! 0.05 as compared with ropivacaine
(ROPI) 0.1% and bupivacaine (BUPI) 0.1%.
Table 1. Patient Data
ROPI 0.1% ROPI 0.2% BUPI 0.1% BUPI 0.2%
Sex (M/F) 9/6 6/9 8/7 7/8
Age (yr) 60# 15 57# 16 61# 7 61 # 14
Height (cm) 168# 9 164# 10 170# 8 170# 11
Weight (kg) 70# 14 67# 14 75# 13 73# 16
Type of surgery (gastric/hepatic/pancreatic/colic/gynecologic) 1/2/3/9/0 0/1/3/9/2 2/2/2/8/1 1/1/4/8/1
Duration of anesthesia (min) 334# 117 335# 194 347# 97 323# 114
Intraoperative sufentanil (!g) 20 # 7 20# 11 20# 11 23 # 9
ASA physical status (I/II/III) 3/10/2 0/13/2 3/7/5 4/9/2
Values are mean # sd or number.
ROPI " ropivacaine; BUPI " bupivacaine.
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when given alone (5), its combination with a lipophilic
opioid, such as fentanyl (12) or sufentanil (7,13), al-
lows the reduction of ROPI requirements to approxi-
mately 10 mg/h and decreases the incidence of motor
block. Accordingly, in our study, the dose of ROPI
administered by the patients in combination with a
very small dose of epidural morphine ranged between
8 and 14 mg/h. Interestingly, doubling the ROPI con-
centration did not significantly decrease PCEA de-
mands. As a consequence, ROPI consumption was
significantly larger in the 0.2% group compared with
the 0.1% group without improving quality of analge-
sia. A large volume of diluted solution of ROPI re-
duces the dose requirements of ROPI (12). Together
these data suggest that small concentrations of ROPI,
0.1% or even 0.05%, are preferable, and a minimum
volume of 5–10 mL/h is required (8,12).
We selected a very small dose of morphine without
an initial dose. Indeed, a pilot study showed that the
epidural administration of an epidural bolus injection
of 2 mg of morphine followed by a continuous epi-
dural infusion of morphine 0.2 mg/h, as used by
Kehlet and Mogensen (11), resulted in almost no con-
sumption of local anesthetic by the patients. Accord-
ingly, Dahl et al. (10) reported no difference in pain
scores at rest whether patients were treated with those
small doses of epidural morphine alone or the same
dose of morphine combined with a continuous infu-
sion of BUPI 10 mg/h. We therefore administered a
smaller dose of morphine that required local anes-
thetic to produce satisfactory analgesia to enable us to
detect potential differences in dose requirements
among our four groups.
The progressive reduction over time in local anes-
thetic consumption observed in the four groups was
multifactorial. This might reflect a reduction in post-
operative pain. The progressive onset of morphine
analgesia might also contribute to the decreasing con-
sumption of local anesthetic. Indeed, no initial dose of
morphine was given, and the onset time of morphine
epidural analgesia is slow. Although we used a very
small dose of epidural morphine, that dose was effec-
tive and prevented the tachyphylaxis that is usually
observed when local anesthetics are used alone
(14,15). Furthermore, ROPI requirements were smaller
than those reported in studies using ROPI alone (5).
Patients from each group reported similar pain
scores at rest, during mobilization, and while cough-
ing. Because a patient provided with PCEA has free
access to analgesia to obtain satisfactory pain control,
it is not surprising that pain scores at rest were not
different in the four groups. Furthermore, the sensory
block achieved with the four local anesthetic solutions
was also comparable. As a consequence, pain scores
Table 2. Local Anesthetic Consumption After Surgery
ROPI 0.1% BUPI 0.1% ROPI 0.2% BUPI 0.2%
12th h 93# 44 mg 95 # 40 mg 156# 73 mg 152# 115 mg
0–12 h (93# 44 mL) (95 # 40 mL) (78# 36 mL) (76# 56 mL)
24th h 181# 82 mg 185# 60 mg 312# 132 mg* 261# 182 mg
12–24 h (88 # 44 mL) (90# 37 mL) (78# 36 mL) (55# 39 mL)
36th h 248# 120 mg 249# 82 mg 445# 205 mg* 355# 237 mg
24–36 h (66 # 47 mL) (64# 30 mL) (67# 42 mL) (47# 37 mL)
48th h 314 # 151 mg 310 # 116 mg 573# 304 mg* 438# 253 mg
36–48 h (66 # 38 mL) (61# 44 mL) (64# 56 mL) (42# 28 mL)
60th h 354 # 167 mg 357# 139 mg 645# 335 mg* 480# 257 mg
48–60 h (41 # 32 mL) (47 # 35 mL) (38# 33 mL) (21# 24 mL)
Values are mean # sd.
Total cumulated amount of local anesthetic in mg. Between parentheses is the volume administered during each 12 h period in mL/12 h.
* P ! 0.05 as compared with ROPI 0.1%.
BUPI " bupivacaine; ROPI " ropivacaine.
Table 3. Tramadol Consumption, Incidence of Motor Block and Side Effects
ROPI 0.1% ROPI 0.2% BUPI 0.1% BUPI 0.2%
Tramadol (Day 1) 11/2/2 10/4/1 14/1/0 12/2/1
Tramadol (Day 2) 14/1/0 13/2/0 12/2/1 14/1/0
Motor block 0 1 2 1
Motor block &2 0 0 0 1
Nausea 3 2 5 2
Vomiting 0 0 1 0
Pruritus 4 1 3 1
Hypotension 6 6 6 4
Tramadol values are the number of patients requiring 0/1/2 dose(s) of 100 mg tramadol after surgery. Values are mean # sd. The other values are number
of subjects presenting the events at least once during the epidural treatment.
ROPI " ropivacaine; BUPI " bupivacaine.
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during mobilization and coughing did not differ
among the groups. Recently, Pouzeratte et al. (7) also
reported similar analgesia at rest with PCEA using
either BUPI 0.125% or ROPI 0.125%, both combined
with sufentanil 0.5 !g/mL. However, pain scores dur-
ing coughing were significantly lower in the BUPI
0.125% group. We administered morphine, whereas
they selected a lipophilic opioid, sufentanil. The more
cephalad spread of hydrophilic opioid in the cerebro-
spinal fluid as compared with lipophilic opioid may
be beneficial in case of upper abdominal surgery.
However, we do not think that the choice of opioid
can explain the discrepancy. Indeed, because they in-
serted the epidural catheter at the thoracic level,
sufentanil exerted its analgesic effect in the metameres
involved by the surgery. Moreover, others reported
comparable pain scores during mobilization, cough-
ing, and even ambulation whenever BUPI 0.125% or
ROPI 0.125% were used with another lipophilic opi-
oid, fentanyl (16). Rather, pain scores during coughing
reported by patients treated with BUPI 0.125% in the
Pouzeratte et al. (7) study were abnormally low (mean
scores inferior to 20 mm). In a previous study by the
same authors (17), patients provided with the same
analgesic regimen reported pain scores during cough-
ing between 30 and 40 mm, which are comparable
with the scores of the patients in our study. Why pain
scores during coughing were so low in the group
treated with BUPI 0.125% is not clear.
No significant differences were observed among the
four groups with regard to the incidence and the
degree of motor block of the legs. The reduced con-
sumption of ROPI in our study resulted in an infre-
quent incidence of motor block of the legs. Only one
patient from the BUPI 0.2% group experienced a high-
grade (Bromage scale &2) motor block of the legs. No
motor block was detected in any patient from the
ROPI 0.1% group.
Liu et al. (8) reported more frequent and more in-
tense motor block when the same dose of ROPI was
given as a 0.2% solution as compared with a 0.1%
solution, although their patients used similar doses as
those given in our study (60–80 mg of ROPI every
6 h). In their study, an increased incidence of motor
block in the ROPI 0.2% group was clinically evidenced
only when patients were tested for their ability to
ambulate, which we did not assess. No significant
differences were observed between the 0.1% and 0.2%
solutions when they used the Bromage scale, as in our
study. However, fine assessment of the intensity of
motor block using surface electromyography to mea-
sure the isometric maximal force contraction of the
quadriceps demonstrated significant reduction in
quadriceps strength in the 0.2% group as compared
with the 0.1% group (8). The location of the epidural
catheter might also explain these differences. Whereas
their epidural catheters were inserted at the lumbar
levels, our patients had thoracic catheters. Accord-
ingly, the use of 0.2% ROPI (~10 mg/h) for thoracic
epidural analgesia in patients undergoing major ab-
dominal surgery did not disturb early ambulation
(18).
The incidence of mild orthostatic hypotension was
similar to that reported in other studies (18,19). The
decrease in blood pressure was transient, quickly re-
solved by increasing infusion of crystalloid fluid, and
did not prevent the patient from sitting in his arm-
chair. It should be remembered that our patients un-
derwent major abdominal surgery. It is not unusual
that these patients have orthostatic hypotension the
day after surgery, even in the absence of epidural
analgesia with local anesthetic. Because all our pa-
tients were given epidural local anesthetic, it is impos-
sible to determine the contribution of epidural anal-
gesia to the incidence of orthostatic hypotension.
The potency ratio between ROPI and BUPI has been
the subject of many debates. When anesthetic doses
and large concentrations of these local anesthetics
were administered, potency ratio (ROPI/BUPI) was
approximately 1.5:1 (20). When the concentrations
used were small, these two local anesthetics seemed
equipotent (16,20–22). Accordingly, in our study, the
potency ratio between the two 0.2% solutions was 1.3,
whereas this ratio was 1 between the two 0.1% solu-
tions. It should be noted that when these small con-
centrations are given, the profile and the incidence of
local anesthetic-induced side effects are similar
whether ROPI or BUPI is used.
In conclusion, dose requirements of ROPI when
combined with small doses of epidural morphine
range approximately 10 mg/h. The use of a 0.1%
ROPI solution allows reduction of the doses re-
quired as compared with the 0.2% solution for
equivalent analgesia. Small concentrated solutions
of ROPI and BUPI have similar efficacy, potency,
and side effects profiles.
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